Castle Biosciences Inc · Brief

Next report

1 day

Nov 5 · after closeconfirmedQ3 FY26

Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory

4 of 8≥ implied

avg implied: ±14.0%
avg realized: ±14.3%

Feb 27 '25±11.9%▼−14.24%×1.20

May 5 '25±17.3%▼−11.36%×0.66

Aug 4 '25±10.4%▲+32.83%×3.17

Nov 3 '25±14.8%▲+21.70%×1.47

Jan 13 '26±7.7%▼−0.05%×0.01

Q1 FY26±15.2%▼−7.25%×0.48

May 6 '26±19.4%▼−22.26%×1.15

Q2 FY26±15.4%▲+4.52%×0.29

quarterimplied−35%0+35%realized×

Q2 FY26±15.4%▲+4.52%×0.29

May '26±19.4%▼−22.26%×1.15

Q1 FY26±15.2%▼−7.25%×0.48

Jan '26±7.7%▼−0.05%×0.01

Nov '25±14.8%▲+21.70%×1.47

Aug '25±10.4%▲+32.83%×3.17

2 older reports

May '25±17.3%▼−11.36%×0.66

Feb '25±11.9%▼−14.24%×1.20

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · confirmed

Bull2

175managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+6.18%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

44.00%of revenue from the largest disclosed customer MedicareSEC filings

30managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

CSTL report session

Suppliers 1

TMOThermoFisher Scientific×0.15

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 22impliedImplied move: ±12.7% into Nov 5 earnings (Oct 22 close).Source

Oct 15report dateEarnings date confirmed: Nov 5, after close.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.